Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;10(3):e333.
doi: 10.1016/S2214-109X(21)00588-X.

Fluvoxamine for the treatment of COVID-19 - Author's reply

Gilmar Reis  1 , Edward Mills  2
Affiliations
Comment

Fluvoxamine for the treatment of COVID-19 - Author's reply

Gilmar Reis et al. Lancet Glob Health. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Reis G, Dos Santos Moreira-Silva EA, Silva DCM, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022;10:e42–e51. - PMC - PubMed
    1. Montori V, Permanyer-Miralda G, Ferreira-Gonzales I, et al. Validity of composite endpoints in clinical trials. BMJ. 2005;330:5945–5996. - PMC - PubMed
    1. US Food and Drug Administration Fact sheet for healthcare providers: emergency use authorization for Paxlovid. https://www.fda.gov/media/155050/download
    1. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl J Med. 2021 doi: 10.1056/NEJMoa2116044. published online Dec 16. - DOI - PMC - PubMed